BEST OF ESMO

28-29 NOV, 2026
THE LALIT JAIPUR,
RAJASTHAN
Register Now Abstract Submission
00 DAYS
00 HRS
00 MINS
00 SECS
About The Conference

BEST OF ESMO 2026

From the latest evidence at ESMO Congress 2026 to its clinical relevance in India.

A focused two-day scientific meeting bringing together the latest clinical trial data, emerging therapies, biomarker-driven advances, guideline developments and expert perspectives from the ESMO Congress 2026 in Madrid.

Read More
Highlights

CONFERENCE HIGHLIGHTS

Following its successful India debut in 2025, Best of ESMO returns in 2026 with a larger platform for scientific exchange, expert perspectives and meaningful oncology discussions.

300+ Participants
15+ Industry Stalls
75+ Expert Faculty
5+ Focused Sessions
Why ESMO

WHY BEST OF ESMO

Bridging Global Evidence And Clinical Practice In India

Every year, the ESMO Congress brings together the global oncology community around new clinical evidence, emerging therapies, translational research and developments that may influence the way cancer is diagnosed and treated.

Best of ESMO 2026 brings the most relevant scientific developments from the ESMO Congress in Madrid to India, creating a focused forum to examine what has changed, what the evidence means, and how these developments may translate into clinical practice.

Across two days, leading experts will explore the data behind emerging treatment strategies, evolving biomarkers, advances in precision oncology and updates in clinical guidance, while placing international evidence in the context of Indian oncology practice.

Scientific Programme

WHAT THE SCIENCE WILL COVER

Laboratory researcher looking through a microscope

Practice-Changing Evidence

A focused review of the latest clinical trial findings, including important new data presented at ESMO Congress 2026, with attention to efficacy, safety and patient outcomes.

  • Next-Generation Therapies

    Exploration of evolving treatment approaches across immunotherapy, antibody-drug conjugates, targeted therapies and other emerging therapeutic strategies.

  • Precision Oncology & Biomarkers

    A closer look at molecular profiling, predictive biomarkers, liquid biopsy and other developments shaping treatment selection and patient stratification.

  • Guidelines, Sequencing & Clinical Decisions

    Updates in ESMO recommendations and expert discussion around treatment sequencing, lines of therapy and translating evidence into clinical decision-making.

  • Multidisciplinary Perspectives

    Disease-focused discussions bringing together perspectives across medical, surgical, radiation and diagnostic oncology, alongside pathology and molecular medicine where relevant.

From Evidence to Indian Practice

Discussion of clinical applicability, access, diagnostics, treatment availability and other considerations that influence how global advances can be contextualised within the Indian healthcare setting.

Our Attendees

WHO SHOULD ATTEND?

Medical Oncologists
Radiation Oncologists
Surgical Oncologists
Hemato Oncologists
Onco-Pathologists
Radiologists
Pyscho Oncologists
Medical Students
Onco-Nutritionist
Geneticists
Pharmacists
Researchers
Onco-Nurses

© 2026 Best Of ESMO. All Rights Reserved.

Designed & Developed by Global Healthcare Academy